APA (7th ed.) Citation

Gahlawat, A. W., Witte, T., Sinn, P., & Schott, S. (2023). Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer. Scientific reports, 13, . https://doi.org/10.1038/s41598-023-32243-x

Chicago Style (17th ed.) Citation

Gahlawat, Aoife Ward, Tania Witte, Peter Sinn, and Sarah Schott. "Circulating Cf-miRNA as a More Appropriate Surrogate Liquid Biopsy Marker than CfDNA for Ovarian Cancer." Scientific Reports 13 (2023). https://doi.org/10.1038/s41598-023-32243-x.

MLA (9th ed.) Citation

Gahlawat, Aoife Ward, et al. "Circulating Cf-miRNA as a More Appropriate Surrogate Liquid Biopsy Marker than CfDNA for Ovarian Cancer." Scientific Reports, vol. 13, 2023, https://doi.org/10.1038/s41598-023-32243-x.